N@N

Market Maker Surveillance Report. OSTK, NYMX, CHTP, GSIT, ANGI, PRLB, Winning Stocks With Lowest Price Friction For Thursday,

October 25, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4034 companies with "abnormal" market making, 2883 companies with positive Friction Factors and 2331 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Overstock.com Inc (NASDAQ:OSTK), Nymox Pharmaceutical Corp (NASDAQ:NYMX), Chelsea Therapeutics International Ltd (NASDAQ:CHTP), GSI Technology Inc (NASDAQ:GSIT), Angie's List Inc (NASDAQ:ANGI), Proto Labs Inc (NYSE:PRLB). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  OSTK    $2.560    23.40%    494,188      57.36%    365,617      42.43%    128,571      502     
  NYMX    $0.960    15.34%    92,305       60.36%    60,533       39.58%    31,772       331     
  CHTP    $0.370    28.03%    2,457,538    55.03%    1,991,444    44.59%    466,094      12,597  
  GSIT    $1.240    27.62%    164,087      63.77%    93,136       36.19%    70,951       572     
  ANGI    $2.310    25.45%    2,134,382    51.18%    2,002,910    48.03%    131,472      569     
  PRLB    $6.030    20.15%    358,605      32.81%    243,417      22.27%    115,188      191     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows OSTK with a dollar gain Thursday of $2.56000 and a Friction Factor of 502 shares. That means that it only took 502 more shares of buying than selling to move OSTK higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Overstock.com Inc (NASDAQ:OSTK) - Overstock.com, Inc. operates as an online retailer offering closeout and discount brand, and non-brand name merchandise in the United States. Its merchandise offerings include bed-and-bath goods, home decor, kitchenware, watches, jewelry, electronics and computers, sporting goods, apparel, and designer accessories, as well as comprise furniture, home and garden products, shoes, and media products. The company also sells books, magazines, CDs, DVDs, and video games. In addition, Overstock.com offers an online auction service, which operates as an online marketplace for buying and selling goods and services, as well as for listing cars and real estate for sale. It offers its products and services through its Web site, overstock.com, as well as operates O.biz, a Website where customers can shop for bulk and business related items. The company was formerly known as D2Discounts Direct and changed its name to Overstock.com, Inc. in October 1999. Overstock.com, Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah..

Nymox Pharmaceutical Corp (NASDAQ:NYMX) - Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs and diagnostic devices in Canada, the United States, and Europe. The companys products include AlzheimAlert, a urinary test that aids physicians in the diagnosis of Alzheimers disease; and NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. Its products under development comprise NX-1207, which is in Phase III clinical trials for the treatment of benign prostatic hyperplasia; and NX-1207, which is ready for human clinical trials for the treatment of hepatocellular carcinoma and localized prostate cancer. The companys products in the preclinical stage comprise NXC-4720, an antibacterial agent for the treatment of E. coli O157:H7 bacterial contamination in hamburger meat and other food and drink products, and for the treatment of urinary tract and other bacterial infections in humans; NXB-4221 for the treatment of difficult chronic and persistent urinary tract infections; NXB-5886 for the treatment of streptococcal infection; and NXT-1021 for the treatment of staphylococcal infection. It is also developing therapeutics for Alzheimers disease; drugs for the treatment of Alzheimers disease that target spherons; and therapeutic products for oncological indications, as well as holds various diagnostic markers and technologies, including a patented platform for point-of-care testing. Nymox Pharmaceutical was founded in 1989 and is based in St. Laurent, Canada..

Chelsea Therapeutics International Ltd (NASDAQ:CHTP) - Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases. The companys compounds target various prevalent medical conditions, primarily rheumatoid arthritis, psoriasis, cancer, other immunological disorders, and neurogenic orthostatic hypotension associated with Parkinsons disease and other autonomic disorders. It offers Droxidopa, an orally active synthetic precursor of norepinephrine for the treatment of symptomatic neurogenic orthostatic hypotension, freezing gait in Parkinsons disease, and intradialytic hypotension in Japan. The company develops droxidopa in three indications, such as neurogenic orthostatic hypotension, intradialytic hypotension, and fibromyalgia. It also develops a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, such as a portfolio of metabolically inert antifolate molecules, including CH-1504 for the treatment of rheumatoid arthritis that is in a phase II head-to-head clinical trial; and CH-4051, which completed the phase I study designed to determine the maximum tolerated dose based on results of single-ascending and multiple-ascending dose evaluations. In addition, the company develops antifolate program, a platform consisting of a portfolio of dihydroorotate dehydrogenase(DHODH), inhibiting compounds known as the I-3D portfolio, a group of orally active compounds that inhibit the enzyme DHODH for the treatment of autoimmune diseases and transplant rejection. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina..

GSI Technology Inc (NASDAQ:GSIT) - GSI Technology, Inc. designs, develops, and markets static random access memory (SRAM) products for the networking and telecommunications markets primarily in the United States, China, Malaysia, and Singapore. Its SRAM products are incorporated in a range of equipment, such as multi-service access routers, universal gateways, enterprise edge routers, service provider edge routers, optical edge routers, fast Ethernet switches, gigabit Ethernet switches, wireless base stations, ADSL modems, wireless local area networks, Internet protocol phones, and OC192 layer 2 switches. The company offers synchronous SRAM products that are controlled by timing signals, referred to as clocks; and asynchronous SRAM products, which employ a clock-free control interface. Its synchronous SRAM products include Burst and No Bus Turnaround SRAMs for microprocessor cache applications; SigmaQuad products, which are quad data rate synchronous SRAMs for the networking and telecommunications industry; and SigmaRAM products that are designed for use on large format printed circuit boards common in various networking and telecommunication products. The company also serves military, industrial, test equipment, and medical markets. It offers its products primarily to original equipment manufacturers through a network of independent sales representatives and distributors. The company was formerly known as GSI Technology and changed its name to GSI Technology, Inc. in June 2004. GSI Technology, Inc. was founded in 1995 and is headquartered in Sunnyvale, California..

Angie's List Inc (NASDAQ:ANGI) - .

Proto Labs Inc (NYSE:PRLB) - .

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net